Indoco Remedies Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported total income from operations of INR 2,781.9 million compared to INR 2,604.3 million a year ago. Profit from operation before other income, finance costs, and exceptional items were INR 251.5 million compared to INR 275.3 million a year ago. Profit from ordinary activities before tax was INR 233.6 million compared to INR 221.1 million a year ago. Net profit for the period was INR 175.9 million or INR 1.91 per basic and diluted share compared to INR 189.8 million or INR 2.06 per basic and diluted share a year ago. For the nine months, the company reported total income from operations of INR 8,163.5 million compared to INR 7,417.2 million a year ago. Profit from operation before other income, finance costs, and exceptional items were INR 754.2 million compared to INR 850.6 million a year ago. Profit from ordinary activities before tax was INR 709.5 million compared to INR 760.2 million a year ago. Net profit for the period was INR 595.1 million or INR 6.45 per basic and diluted share compared to INR 613.4 million or INR 6.65 per basic and diluted share a year ago.